Key Takeaways

  1. This analysis suggests that structured encounter counts may miss clinically meaningful differences: the authors previously found similar psychotherapy frequency across groups, but unstructured note review identified distinct content patterns between risk-matched cases and controls.
  2. The topic model was deliberately tuned for discrimination rather than maximum granularity, with 5 topics selected because larger models had marginally higher coherence but substantial overlap, and a 20% topic-proportion threshold chosen because it yielded the greatest number of significant case-control differences across risk tiers.
  3. At higher suicide risk tiers, note content shifted away from Risk, Treatment Planning, Evaluation, and Medication themes and toward Psychosocial themes, indicating that psychotherapy documentation in the highest-risk patients may be dominated more by inpatient routines, group interventions, and care progress than by collaborative planning or medication-related discussion.
  4. The Medication topic was the most consistent differentiator, with controls showing significantly higher proportions of medication-related notes at every risk tier; clinicians may want to consider whether medication management and documentation become less consistent in patients who later die by suicide.
  5. The Psychosocial topic became less useful for separating cases from controls as risk increased, with no significant difference between high-risk cases and controls, suggesting that group-based and inpatient-oriented care may homogenize documentation patterns in the highest-risk subgroup.
  6. Interpretation should stay at the level of care patterns rather than treatment efficacy: the study could not distinguish EBP from non-EBP psychotherapy, could not control for specific intervention formats, and used ICD-based PTSD identification and VA-only records, so the findings inform service characterization more than causal conclusions about what prevents suicide.
Read full article
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.